02/18/2026 / By Laura Harris

Republican Sen. Rand Paul of Kentucky introduced legislation last Wednesday that would eliminate long-standing federal liability protections shielding vaccine manufacturers from most civil lawsuits in the United States.
In early 2020, the first Trump administration invoked the PREP Act in declaring COVID-19 a public health emergency, activating broad immunity protections tied to pandemic countermeasures.
Under the statute, the federal government, state governments, manufacturers and distributors of covered countermeasures and licensed health professionals administering them are shielded from “all claims for loss” related to those countermeasures. The primary exception involves cases of death or serious physical injury caused by “willful misconduct,” a legal standard requiring proof that a defendant acted intentionally to achieve a wrongful purpose.
However, data from the federal Vaccine Adverse Event Reporting System (VAERS) show that, as of Jan. 2, 1,673,223 reports of adverse events following COVID-19 vaccination had been submitted, including 38,983 reported deaths, 222,078 hospitalizations, 22,454 heart attacks, and 29,131 cases of myocarditis and pericarditis, among other conditions.
Centers for Disease Control and Prevention (CDC) researchers have acknowledged the “high verification rate” of myocarditis reports submitted to VAERS following mRNA-based COVID-19 vaccination and have suggested that under-reporting is more likely than over-reporting for that condition.
Questions about reporting rates predate the pandemic. A 2010 study affiliated with Harvard Medical School estimated that fewer than 1% of vaccine adverse events are reported to VAERS. Additionally, a 2012 paper referenced a confidential study conducted by Connaught Laboratories, a vaccine manufacturer, which suggested adverse events may be significantly underreported.
International research has also examined potential safety signals. An analysis involving 99 million individuals across eight countries, published in the journal Vaccine, reported statistically higher risks of myocarditis following first, second, and third doses of mRNA-based COVID-19 vaccines, along with possible elevated risks of pericarditis, Guillain-Barré syndrome and cerebral venous sinus thrombosis. The study’s authors said some findings warrant further investigation.
In April 2024, the CDC released approximately 780,000 previously undisclosed reports of serious adverse events following a court order. Separately, a study conducted in Japan reported statistically significant increases in certain cancer deaths following third doses of mRNA-based COVID-19 vaccines and proposed several hypotheses to explain a potential association, while calling for additional research.
Watch the video below that talks about how childhood vaccines have not gone through safety trials.
This video is from The People Of The Qur’an (TPQ) channel on Brighteon.com.
Sources include:
Tagged Under:
accountability, big government, Big Pharma, chemical violence, covid-19, liability, pharmaceutical fraud, progress, vaccine damage, Vaccine deaths, Vaccine injuries, vaccine manufacturers, vaccine wars, vaccines
This article may contain statements that reflect the opinion of the author